Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Expert Opinion on Biological Therapy
|
June 15, 2005
Interferon alpha for the treatment of advanced renal cancer
Alain Ravaud, Marie-Sarah Dilhuydy
British Journal of Haematology
|
April 12, 2007
Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia
Marie-Sarah Dilhuydy, Thomas Jouary, Hélène Demeaux, et al.
The Lancet. Haematology
|
August 27, 2021
eBEACOPP or A-AVD in advanced Hodgkin lymphoma: (re)thinking the toxicities in the PET-driven strategies era
Jean Galtier, Pauline Brice, Krimo Bouabdallah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 5, 2010
Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study
Marie-Sarah Dilhuydy, Thierry Lamy, Charles Foussard, et al.
Intensive Care Medicine
|
November 9, 2006
Decrease in circulating dendritic cells predicts fatal outcome in septic shock
Olivier Guisset, Marie-Sarah Dilhuydy, Rodolphe Thiébaut, et al.
Journal of Leukocyte Biology
|
February 22, 2023
Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion
Corentin Le Saos-Patrinos, Séverine Loizon, Atika Zouine, et al.
Annales De Biologie Clinique
|
October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients
Victor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
Leukemia & Lymphoma
|
July 28, 2020
Vinblastine for elderly and frail patients with Hodgkin lymphoma
Lucie Meynard, Jean Galtier, Simon Favre, et al.
British Journal of Haematology
|
February 11, 2019
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies
Jan A Burger, Paula Cramer, Paul M Barr, et al.
Plos One
|
May 12, 2009
The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells
Gwendaline Guidicelli, Benjamin Chaigne-Delalande, Marie-Sarah Dilhuydy, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Expert Opinion on Biological Therapy
|
June 15, 2005
Interferon alpha for the treatment of advanced renal cancer
Alain Ravaud, Marie-Sarah Dilhuydy
British Journal of Haematology
|
April 12, 2007
Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia
Marie-Sarah Dilhuydy, Thomas Jouary, Hélène Demeaux, et al.
The Lancet. Haematology
|
August 27, 2021
eBEACOPP or A-AVD in advanced Hodgkin lymphoma: (re)thinking the toxicities in the PET-driven strategies era
Jean Galtier, Pauline Brice, Krimo Bouabdallah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 5, 2010
Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study
Marie-Sarah Dilhuydy, Thierry Lamy, Charles Foussard, et al.
Intensive Care Medicine
|
November 9, 2006
Decrease in circulating dendritic cells predicts fatal outcome in septic shock
Olivier Guisset, Marie-Sarah Dilhuydy, Rodolphe Thiébaut, et al.
Journal of Leukocyte Biology
|
February 22, 2023
Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion
Corentin Le Saos-Patrinos, Séverine Loizon, Atika Zouine, et al.
Annales De Biologie Clinique
|
October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patients
Victor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
Leukemia & Lymphoma
|
July 28, 2020
Vinblastine for elderly and frail patients with Hodgkin lymphoma
Lucie Meynard, Jean Galtier, Simon Favre, et al.
British Journal of Haematology
|
February 11, 2019
Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies
Jan A Burger, Paula Cramer, Paul M Barr, et al.
Plos One
|
May 12, 2009
The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells
Gwendaline Guidicelli, Benjamin Chaigne-Delalande, Marie-Sarah Dilhuydy, et al.
Page
of 5